Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

RAPTORplus Right-time Adaptive Particle Therapy Of canceR - Personalisation through anatomical plus biological adaptation

Coordinator
Helmholtz-Zentrum Dresden-Rossendorf eV, Germany
Runs
1 January 2026 to 31 December 2029
Status
Running
EU funding
€4.5m
Total cost
—
Partners
34 organisations in 13 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226720

What the project is doing

In the project's own words, from its summary on CORDIS.

The RAPTORplus consortium gathers excellent research institutions, academic hospitals and non-academic particle therapy (PT) centres, industrial corporations and public organisations. It offers a platform for intercultural, interdisciplinary and inter-sectoral training and education of doctoral candidates (DCs) in the field of medical physics focussing on right-time adaptive PT. The assembled infrastructure and expertise from academia, clinic and industry is needed to address the challenges of personalised adaptive PT.PT is a precise form of radiotherapy with a growing number of centres treating patients.

It targets localised cancers while sparing healthy tissue, but might deliver suboptimal doses in case of anatomical changes. To exploit the full potential of PT, fast and safe online treatment adaptations must be enabled and performed if beneficial, e.g. indicated by image-based biomarkers, biological models or other response data. The research projects conducted at academic and non-academic facilities will tackle (1) the efficient realisation of online-adaptive PT (OAPT), (2) the technological completion for broad and safe use of OAPT, and (3) a further treatment personalisation by biomarker-based adaptation.

The network uses a multi-sectoral approach to ensure that the DCs develop scientific, clinical and practical industry-relevant skills. The holistic training programme includes in-person training camps, online trainings, project-specific secondments, training in tutoring, research communication, entrepreneurship and science policy, and opportunities to participate in international conferences and professional networks.

RAPTORplus will train the next generation of research leaders, medical physicists and entrepreneurs to be aware of the necessity of right-time adaptive PT. They will drive innovation in the coming era of adaptive PT and improve cancer care through enduring international and cross-sectoral collaborations based on their transformative thinking.

Who is involved

OrganisationCityCountryRole
Helmholtz-Zentrum Dresden-Rossendorf eVDresdenGermanyCoordinator
Medizinische Universitaet WienWienAustriaAssociatedpartner
European Society for Radiotherapy and OncologyBruxelles / BrusselBelgiumAssociatedpartner
Ion Beam Applications SAOttignies Louvain La NeuveBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandAssociatedpartner
Paul Scherrer InstitutVilligen PsiSwitzerlandAssociatedpartner
Particle Therapy Co-Operative Group (PTCOG)Villigen-PSISwitzerlandAssociatedpartner
Universitaet BernBernSwitzerlandAssociatedpartner
Brainlab SeMunchenGermanyParticipant
Gsi Helmholtzzentrum Fur Schwerionenforschung GmbHDarmstadtGermanyAssociatedpartner
Klinikum Der Ludwig-Maximilians-Universitat MunchenMunchenGermanyAssociatedpartner
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Siemens Healthineers AGForchheimGermanyAssociatedpartner
Technische Universitaet DresdenDresdenGermanyParticipant
Universitatsklinikum HeidelbergHeidelbergGermanyAssociatedpartner
Aarhus UniversitetAarhus CDenmarkParticipant
Universidad De NavarraPamplonaSpainParticipant
Fondazione Centro Nazionale Di Adroterapia OncologicaPavia PvItalyAssociatedpartner
Istituto Nazionale Di Fisica NucleareFrascatiItalyParticipant
Politecnico Di MilanoMilanoItalyParticipant
Universita Degli Studi Di TorinoTorinoItalyAssociatedpartner
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
European Federation of Organisations for Medical PhysicsUtrechtNetherlandsAssociatedpartner
Holland Particle Therapy Centre BVDelftNetherlandsAssociatedpartner
Helse Bergen HfBergenNorwayAssociatedpartner
Hogskulen Pa VestlandetBergenNorwayParticipant
Norges Teknisk-Naturvitenskapelige Universitet NTNUTrondheimNorwayAssociatedpartner
Raysearch Laboratories AB (publ)StockholmSwedenParticipant
Stockholms UniversitetStockholmSwedenAssociatedpartner
Cosylab Laboratorij Za Kontrolne Sisteme DdLjubljanaSloveniaParticipant
Univerza V LjubljaniLjubljanaSloveniaAssociatedpartner
The University of ManchesterManchesterUnited KingdomParticipant
The General Hospital CorporationBoston MaUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI